2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
131
Brain Neoplasms
128
Prostatic Neoplasms
108
Neoplasm Metastasis
88
Lung Neoplasms
73
Carcinoma, Hepatocellular
71
Pancreatic Neoplasms
69
Breast Neoplasms
49
Melanoma
44
Carcinoma, Renal Cell
36
Neoplasms
34
Colorectal Neoplasms
26
Squamous Cell Carcinoma of Head and Neck
25
Glioblastoma
24
Liver Neoplasms
20
Head and Neck Neoplasms
17
Small Cell Lung Carcinoma
15
Sarcoma
13
Kidney Neoplasms
13
Glioma
12
Urinary Bladder Neoplasms
10
Recurrence
9
Gliosarcoma
8
Ovarian Neoplasms
7
Central Nervous System Neoplasms
7
Adenocarcinoma of Lung
7
Adenocarcinoma
7
Radiation Injuries
6
Prostate Cancer Metastatic
6
Neuroma, Acoustic
6
Interventions
enzalutamide
20
Abiraterone Acetate
11
Prednisone
7
Docetaxel
7
radium Ra 223 dichloride
6
darolutamide
5
abiraterone
5
apalutamide
3
olaparib
2
niraparib
2
cabazitaxel
2
atezolizumab
2
Pluvicto
2
Nivolumab
2
zimberelimab
1
xentuzumab
1
tasquinimod
1
sacituzumab govitecan
1
sabizabulin
1
quemliclustat
1
pembrolizumab
1
ipatasertib
1
ibrutinib
1
gedatolisib
1
gallium 68 PSMA-11
1
fludrocortisone acetate
1
TVB-2640
1
Standard of Care
1
Rosuvastatin Calcium
1
Radium-223
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms, Castration-Resistant
×
Radiosurgery
×
Clear all
NCT06276465
2024-12-20
PEACE8
UNICANCER
Phase 3
Recruiting
336 enrolled